CoChat

Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study

Muratori, Paolo, Efe, Cumali, Muratori, Luigi, Ozaslan, Ersan, Schiano, Thomas, Yoshida, Eric M., Heurgué-Berlot, Alexandra, Lalanne, Claudine, Lenzi, Marco, Wahlin, Staffan · 2017 · European Journal of Gastroenterology & Hepatology

The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.

Abstract

Background/aim: Antimitochondrial antibody (AMA) positivity is the serological marker of primary biliary cholangitis (PBC), but can also be sporadically detected in autoimmune hepatitis (AIH). Little is known about the clinical significance of AMA in AIH. Patients and methods: We recruited 47 AMA-positive AIH cases from several centres and compared them with 264 well-characterized Italian AIH patients. Cases with any features of PBC were excluded. Results: In univariate analysis, AMA-positive AIH patients were older (46 vs. 36, P =0.002) and more responsive to immunosuppression (74 vs. 59%, P =0.05), but no differences were observed between the two groups after logistic regression using AMA as a dependent variable. None of the AMA-positive AIH patients showed signs of evolving PBC features after a median follow-up of up 47 months. AMA was detected in combination with all serological AIH markers except antiliver kidney microsome type 1 and antiliver cytosol type 1. AMA was the only marker of autoimmunity in eight cases. Conclusion: We found no differences between AIH with and without AMA. The groups had similar clinical, biochemical and histological features. AMA-positive AIH patients did not evolve towards PBC. In some cases, AMA was the only autoantibody.

Overview

Integrity signals

Registry

Crossref · 10.1097/meg.0000000000000870

Cites

29 of 29 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 29 references

Cited by

See all 19

Metadata

Authors
Muratori, P., Efe, C., Muratori, L., Ozaslan, E., Schiano, T., Yoshida, E. M., Heurgué-Berlot, A., Lalanne, C., Lenzi, M., & Wahlin, S.
Affiliations
  • IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola (IT)
  • Hacettepe University (TR)
  • Department of Gastroenterology, Numune Education and Research Hospital, Ankara, Turkey
  • Mount Sinai Hospital (US)
  • University of British Columbia (CA)
  • Department of Hepato-Gastroenterology, CHU Reims, Reims, France
  • Department of Gastroenterology and Hepatology, Hepatology Division, Centre for Digestive Disease, Karolinska Institute, Stockholm, Sweden
Corresponding author
  • Muratori, Paolo
  • Muratori, Luigi
Venue
European Journal of Gastroenterology & Hepatology
Published
2017-07
Volume
29
Issue
7
Pages
777-780
ISSN
0954-691X (ISSN-L)
OpenAlex
W2602518144
Cited by
19
References
29
Citations by year
2025: 2 · 2023: 3 · 2022: 4 · 2020: 1 · 2019: 4 · 2018: 4 · 2017: 1
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Gastroenterology & Hepatology (publishedVersion)
  • PubMed (publishedVersion)
  • Archivio istituzionale della ricerca (Alma Mater Studiorum Università di Bologna) (submittedVersion)
Topics
  • Health Sciences › Medicine › Hepatology › Liver Diseases and Immunity
  • Health Sciences › Medicine › Rheumatology › IgG4-Related and Inflammatory Diseases
  • Health Sciences › Medicine › Surgery › Pediatric Hepatobiliary Diseases and Treatments
Keywords
antimitochondrial antibodies, autoimmune hepatitis, primary biliary cirrhosis, serological markers, autoantibodies, disease progression
MeSH terms
Adolescent, Adult, Aged, Aged, 80 and over, Autoantibodies, Child, Child, Preschool, Cholangitis, Europe, Female, Humans, Immunosuppressive Agents, Male, Middle Aged, Mitochondria, North America, Serologic Tests, Biomarkers, Chi-Square Distribution, Logistic Models, Case-Control Studies, Treatment Outcome, Hepatitis, Autoimmune, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. https://app.cochat.ai/papers/10.1097/meg.0000000000000870
The paper
Muratori, P., Efe, C., Muratori, L., Ozaslan, E., Schiano, T., Yoshida, E. M., Heurgué-Berlot, A., Lalanne, C., Lenzi, M., & Wahlin, S. (2017). Clinical implications of antimitochondrial antibody seropositivity in autoimmune hepatitis: a multicentre study. European Journal of Gastroenterology & Hepatology. https://doi.org/10.1097/meg.0000000000000870

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.